| Size | Price | Stock |
|---|---|---|
| 1mg | $420 | In-stock |
| 5mg | $1250 | In-stock |
| 10mg | $2000 | In-stock |
| 50 mg | Get quote | |
| 100 mg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-109127 |
| M.Wt: | 562.56 |
| Formula: | C30H26F4N6O |
| Purity: | >98 % |
| Solubility: | DMSO : 100 mg/mL (ultrasonic) |
Berotralstat (BCX7353) is an orally active plasma kallikrein inhibitor. Berotralstat can reduce brain edema and is being studied for glioblastoma and hereditary angioedema[1][2].
IC50 & Target:Plasma kallikrein[1]
In Vitro:Berotralstat inhibits the activity of kallikrein, reduces the generation of kinin, thereby blocking kinin-mediated increased vascular permeability and edema formation. Berotralstat inhibits the proliferation and migration of glioblastoma cells[2].
In Vivo:Berotralstat reduces peritumoral edema in glioblastoma (GB), reduces the frequency of angioedema attacks in case of hereditary angioedema (HAE), but causes side effects such as gastrointestinal symptoms[3].
Berotralstat (8 μM, single dose) inhibits plasma kallikrein activity and reduces contact pathway-initiated thrombin generation in F12+/+ or F12-/- mouse models[4].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.